期刊文献+

烟雾病的脑血流动力学 被引量:6

Cerebral hemodynamics in Moyamoya disease
原文传递
导出
摘要 脑血流动力学变化是烟雾病发生、发展的一个重要病理生理学过程。烟雾病脑血流动力学变化一直是研究的热点。文章主要介绍了脑血流动力学参数及检测方法、烟雾病患者脑血流动力学变化特征及其研究的新进展。 Cerebral hemodynamic changes are an important pathophysiologic process for the occurrence and development of Moyarnoya disease. Cerebral hemodynamic changes of Moyamoya disease have been a research focus. This article mainly reviews the cerebral hemodynamic parameters and detecting methods, characteristics of cerebral hemodynamic changes in patients with Moyamoya disease and their new progress.
出处 《国际脑血管病杂志》 北大核心 2010年第6期441-444,共4页 International Journal of Cerebrovascular Diseases
关键词 烟雾病 脑血管循环 血流动力学 超声检查 多普勒 经颅 磁共振成像 正电子发射体层摄影术 体层摄影术 发射计算机 单光子 体层摄影术 X线计算机 Moyamoya disease Cerebrovascular circulation Hemodynamics Ultrasonography, Doppler, transcranial Magnetic resonance imaging Positron-emission tomography Tomography, emission-computed, single-photon Tomography, X-ray computed
  • 相关文献

参考文献31

  • 1Suzuki J,Takaku A.Cerebrovascular "moyamoya" disease.Disease showing abnormal net-like vessels in base of braia Arch Neurol,1969,20:288-299.
  • 2Kuroda S,Houkin K.Moyamoya disease:current concepts and future perspectives.Lancet Neural,2008,7:1056-1066.
  • 3Scott RM,Smith ER.Moyamoya disease and moyamoya syndrome.N Engl J Med,2009,360:1226-1237.
  • 4Zipfel GJ,Sagar J,Miller JP,et al.Cerebral hemodynamics as a predictor of stroke in adult patients with moyamoya disease:a prospective observational study.Neurosurg Focus,2009,26(4):E6.
  • 5Ogata T,Yasaka M,Inoue T,et al.The clinical features of adult unilateral moyamoya disease:does it have the same clinical charac-teristics as typical moyamoya disease? Cerebrovasc Dis,2008,26:244-249.
  • 6Kang KH,Kim HS,Kim SY.Quantitative cerebrovascular resene measured by acetazolamide-challenged dynamic CT perfusion in ischemic adult Moyamoya disease:initial experience with angiographic correlation.AJNR Am J Neuroradiol,2008,29:1487-1493.
  • 7Tanaka Y,Nariai T,Nagaoka T,et al.Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging-comparison with positron emission tomography.J Cereb Blood How Metab,2006,26:291 -300.
  • 8HeynC,Poublanc J,Crawley A,et al.Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.AJNR Am J Neuroradiol,2010,31:862-867.
  • 9Horn P,Lanczik O,Vajkoczy P,et al.Hemodynamic reserve and high-intensity transient signals in moyamoya disease.Cerebrovasc Dis,2005,19:141-146.
  • 10Seol HJ,Shin DC,Kim YS,et al.Computational analysis of hemodynamics using a two-dimensional model in moyamoya disease.J Neurosurg Pediatr,2010,5:297-301.

同被引文献34

  • 1陈诤,毛颖,周良辅.烟雾病的研究进展[J].国外医学(脑血管疾病分册),2004,12(10):761-764. 被引量:40
  • 2张岩,王江飞,孟国路,王硕,赵继宗.烟雾病研究进展[J].继续医学教育,2006,20(13):64-67. 被引量:11
  • 3刘俊,周政,杨辉.烟雾病的病因与治疗研究进展[J].医学综述,2007,13(14):1098-1100. 被引量:13
  • 4Triltsch AE, Welte M, yon Homeyer P, et al. Bispectral in- dexguided sedation with dexmedetomidine in intensive care: a pro- spective, raildomized, double-blinded, placebo- controlled phase Ⅱ study [J]. Crit Care Med, 2002,30(5):1007-1014.
  • 5Drummond JC, Dan AV, Roth DM, et al. Effect of dexmedetomi- dine on cerebral blood flow velocity, cerebral metabolic rate, and carbon dioxide response in normal humans [ J ]. Anesthesiology, 2008,108 ( 2 ) : 225-232.
  • 6Zheng Y, Cui S, Liu Y, et al. Dexmedetomidine prevents remifen- tanil-indueed postoperative hyperalgesia and decreases spinal tyro- sine phosphorylation of N-methyl-d- aspartate receptor 2B subungit [J]. Brain Res Bull, 2012,87(4-5) :427-431.
  • 7Luginbfuhl M, Gerber A, Schnider TW, et al. Modulation of remifen- tanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans[J]. Anesth Analg, 2003,96(3) :726-732.
  • 8Bajwa SJ, Gupta S, Kaur J, et al. Reduction in the incidence of shiv- ering with perioperative dexmedetomidine: a randomized prospective study[J]. J Anaesthesiol Clin Pharmacol, 2012,28(1) :86-91.
  • 9Smith JL. Understanding and treating moyamoya disease in children[J].Neurosurgical Focus,2009,(14):E4.
  • 10Kuroda S,Houkin K. Moyamoya disease:current concepts and future perspectives[J].Lancet Neurology,2008,(01):1056-1066.doi:10.1016/S1474-4422(08)70240-0.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部